Status:
COMPLETED
Chest dRain rEmoval intrAoperatively afTer thoracOscopic Wedge Resection
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Aarhus University Hospital
Conditions:
Lung Neoplasms
Lung Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chest drain is used routinely after lung surgery. Despite preliminary studies demonstrate the feasibility and safety of intraoperative chest drain removal, these are either retrospective or mainly con...
Eligibility Criteria
Inclusion
- Age ≥18 years.
- Patients referred for elective three port video-assisted thoracoscopic surgery wedge resection of the lung for suspected or confirmed malignant nodules.
- first second forced expiratory volume ≥60% of expected.
- No increased bleeding risk (e.g. preoperative international normalized ratio \>2, overdue discontinuation of anticoagulants according to guidelines by the Danish Society for Thrombosis and Haemostasis, known coagulopathy).
- Not scheduled for frozen section pathology of wedge resection and subsequent lobectomy.
- Able and willing to give informed consent.
Exclusion
- Increased risk of post-operative air leak assessed perioperatively by the surgeon (e.g. severe adhesions, bullous/emphysematous lung tissue, defects of the visceral pleura due to iatrogenic or other reasons, suturing in the lung tissue, deep lung resection).
- Increased risk of post-operative bleeding assessed perioperatively by the surgeon (e.g. intraoperative bleeding or oozing).
- Air leak during intraoperative air leak test.
Key Trial Info
Start Date :
May 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 17 2024
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT05358158
Start Date
May 4 2022
End Date
March 17 2024
Last Update
March 20 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Decker Christensen
Aarhus, Aarhus N, Denmark, 8200
2
Rigshospitalet
Copenhagen, Denmark, 2100